Cas no 2692624-33-0 (1,3-Diolein-D66)
1,3-Diolein-D66 Chemical and Physical Properties
Names and Identifiers
-
- 9-Octadecenoic-2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-d33 acid, 1,1'-(2-hydroxy-1,3-propanediyl) ester, (9Z,9'Z)-
- 1,3-Diolein-D66
-
- Inchi: 1S/C39H72O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(41)43-35-37(40)36-44-39(42)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20,37,40H,3-16,21-36H2,1-2H3/b19-17-,20-18-
- InChI Key: DRAWQKGUORNASA-CLFAGFIQSA-N
- SMILES: C(OC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C(/[H])=C(/[H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])C(O)COC(=O)C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C(/[H])=C(/[H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H]
1,3-Diolein-D66 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Larodan | 72-1866-7-25mg |
1,3-Diolein-D66 |
2692624-33-0 | >99% | 25mg |
€230.00 | 2025-03-07 |
1,3-Diolein-D66 Related Literature
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
-
Hui Liu,Deyong Su,Guolin Cheng,Jimin Xu,Xinyan Wang,Yuefei Hu Org. Biomol. Chem., 2010,8, 1899-1904
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
Additional information on 1,3-Diolein-D66
Comprehensive Overview of 1,3-Diolein-D66 (CAS No. 2692624-33-0): Properties, Applications, and Industry Insights
1,3-Diolein-D66 (CAS No. 2692624-33-0) is a specialized lipid derivative gaining traction in pharmaceutical, cosmetic, and nutraceutical research. This compound, a deuterated form of 1,3-diolein, is engineered for enhanced stability and traceability in metabolic studies. Its unique molecular structure, featuring two oleic acid chains bonded to a glycerol backbone with isotopic labeling (D66), makes it invaluable for advanced analytical techniques like mass spectrometry and NMR.
The growing demand for deuterated lipids in drug development aligns with trends in personalized medicine and precision diagnostics. Researchers frequently search for "1,3-Diolein-D66 solubility" or "CAS 2692624-33-0 supplier," reflecting its niche yet critical role in lipidomics. Unlike conventional lipids, 1,3-Diolein-D66 offers reduced background interference in assays, addressing common pain points in biomarker discovery and pharmacokinetic studies.
In cosmetic formulations, 1,3-Diolein-D66 is explored as a sustainable emollient alternative, coinciding with the "clean beauty" movement. Its biocompatibility and potential to enhance skin permeability resonate with queries like "deuterated compounds in skincare." Manufacturers also value its stability under oxidative stress, a key concern for anti-aging product developers.
From a technical perspective, the compound's 2692624-33-0 identifier ensures precise regulatory compliance, crucial for industries navigating evolving global standards. Recent publications highlight its utility in studying lipid digestion—a hot topic linked to "obesity research biomarkers." The deuterium atoms in D66 enable real-time tracking of lipid metabolism without altering biological behavior, a breakthrough noted in forums discussing "stable isotope labeling techniques."
Supply chain transparency remains a priority for buyers of CAS 2692624-33-0, with certifications like ISO 9001 and USP/NF grades being frequent search criteria. Analytical certificates typically confirm ≥98% purity via HPLC, with GC-MS validating the deuterium enrichment level. Storage recommendations (-20°C under argon) address stability concerns raised in "deuterated compound handling" discussions.
Emerging applications include its use as a reference standard for quantifying 1,3-diolein in complex matrices—addressing FAQs about "lipid quantification methods." The pharmaceutical industry particularly values its role in validating lipid nanoparticle (LNP) drug delivery systems, a trending area due to mRNA vaccine advancements.
Environmental considerations position 1,3-Diolein-D66 favorably compared to synthetic tracers, aligning with "green chemistry" initiatives. Its biodegradability profile responds to increasing searches for "eco-friendly research chemicals." However, researchers should note its limited aqueous solubility (soluble in DMSO, chloroform), a technical aspect often queried alongside "2692624-33-0 solubility data."
Future prospects include potential adoption in PET imaging probes, leveraging the D66 label for improved resolution. This intersects with growing interest in "non-radioactive tracers." Patent analyses reveal expanding claims for deuterated lipids in nutraceuticals, particularly for monitoring omega-9 fatty acid absorption—a niche yet growing market segment.
2692624-33-0 (1,3-Diolein-D66) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)